- Home
- CHRS vs FSFG Comparison
CHRS vs FSFG Comparison
Compare CHRS & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- FSFG
- Stock Information
- Founded
- CHRS 2010
- FSFG 2008
- Country
- CHRS United States
- FSFG United States
- Employees
- CHRS N/A
- FSFG N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- FSFG Savings Institutions
- Sector
- CHRS Health Care
- FSFG Finance
- Exchange
- CHRS Nasdaq
- FSFG Nasdaq
- Market Cap
- CHRS 159.2M
- FSFG 177.8M
- IPO Year
- CHRS 2014
- FSFG 2008
- Fundamental
- Price
- CHRS $1.27
- FSFG $26.88
- Analyst Decision
- CHRS Strong Buy
- FSFG Strong Buy
- Analyst Count
- CHRS 4
- FSFG 3
- Target Price
- CHRS $4.51
- FSFG $31.50
- AVG Volume (30 Days)
- CHRS 1.2M
- FSFG 8.1K
- Earning Date
- CHRS 11-05-2025
- FSFG 10-23-2025
- Dividend Yield
- CHRS N/A
- FSFG 2.38%
- EPS Growth
- CHRS N/A
- FSFG 130.94
- EPS
- CHRS 1.55
- FSFG 3.10
- Revenue
- CHRS $272,209,000.00
- FSFG $79,674,000.00
- Revenue This Year
- CHRS N/A
- FSFG N/A
- Revenue Next Year
- CHRS $109.48
- FSFG $7.37
- P/E Ratio
- CHRS $2.52
- FSFG $8.66
- Revenue Growth
- CHRS 52.33
- FSFG 10.53
- 52 Week Low
- CHRS $0.66
- FSFG $21.63
- 52 Week High
- CHRS $2.43
- FSFG $30.94
- Technical
- Relative Strength Index (RSI)
- CHRS 59.90
- FSFG 49.45
- Support Level
- CHRS $1.26
- FSFG $26.35
- Resistance Level
- CHRS $1.40
- FSFG $27.67
- Average True Range (ATR)
- CHRS 0.08
- FSFG 0.58
- MACD
- CHRS -0.00
- FSFG -0.07
- Stochastic Oscillator
- CHRS 58.06
- FSFG 34.19
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.